Form 4 for MRNA Moderna
Accepted 2021-12-23 00:00:00 ET · period of report 2021-12-22 · accession 0001127602-21-031838 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-23 | 2021-12-22 | MRNA | Bancel Stephane | CEO, Dir | S - Sale | $264.26 | -9,000 | 5.81M | -0.2% | -$2.38M | |
| 2021-12-23 | 2021-12-22 | MRNA | Bancel Stephane | CEO, Dir | G - Gift | — | -4,000 | 5.80M | -0.1% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-22 | S | D | 9,000 | $264.26 | 5,805,535 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-22 | G | D | 4,000 | — | 5,801,535 | D | — | — | (F3) The reported disposition represents a bona fide charitable gift made by the reporting person. |